Drug Shortage Report for AMOXICILLIN SODIUM AND POTASSIUM CLAVULANATE FOR INJECTION

Last updated on 2023-06-20 History
Report ID 188048
Drug Identification Number 02495929
Brand name AMOXICILLIN SODIUM AND POTASSIUM CLAVULANATE FOR INJECTION
Common or Proper name AMOXICILLIN SODIUM AND POTASSIUM CLAVULANATE FOR INJECTION
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) AMOXICILLIN CLAVULANIC ACID
Strength(s) 1000MG 200MG
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS
Packaging size 10 PSOIJ
ATC code J01CR
ATC description BETA-LACTAM ANTIBACTERIALS, PENICILLINS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2023-03-27
Estimated end date 2023-06-16
Actual end date 2023-06-19
Shortage status Resolved
Updated date 2023-06-20
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v12 2023-06-20 English Compare
v11 2023-06-19 French Compare
v10 2023-06-19 English Compare
v9 2023-06-05 French Compare
v8 2023-06-05 English Compare
v7 2023-05-15 French Compare
v5 2023-05-15 English Compare
v6 2023-05-15 English Compare
v4 2023-03-28 English Compare
v3 2023-03-27 French Compare
v2 2023-03-27 English Compare
v1 2023-03-27 English Compare

Showing 1 to 12 of 12